Recommendations Updated for Flu Vaccine in Children
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
TUESDAY, Aug. 29, 2023 -- Recommendations have been updated for influenza vaccination among U.S. children for the 2023 to 2024 season, according to a policy statement and accompanying technical report from the American Academy of Pediatrics (AAP) published online Aug. 29 in Pediatrics.
Sean T. O'Leary, M.D., M.P.H., from the AAP Committee on Infectious Diseases, and colleagues updated recommendations for the routine use of influenza vaccine and antiviral medications for prevention and treatment of influenza during the 2023 to 2024 season.
The AAP recommends influenza vaccination for all children and adolescents from age 6 months and older during the 2023 to 2024 influenza season. Any licensed influenza vaccine product appropriate for age and health status is recommended, with no preference for one product over another. To capture all opportunities for vaccination and achieve the highest possible coverage, providers may administer whichever product is appropriate and readily available. For immunocompromised persons and those with certain chronic medical conditions, live-attenuated influenza vaccines should not be used. The number of influenza doses recommended for children is unchanged in the 2023 to 2024 influenza season and is based on age at first dose administration and vaccination history. Influenza vaccination of all children should be promoted, especially those younger than 5 years and high-risk groups and their contacts unless contraindicated. More details on dosing, timing, high-risk children, pregnant and postpartum individuals, travel considerations, contraindications, and reducing barriers and disparities to vaccination are also outlined in the recommendation.
"As we saw during the 2022-23 flu season, influenza can cause serious illness in children," Kristina Bryant, M.D., from the AAP Committee on Infectious Diseases, said in a statement. "We have safe and effective vaccines that can protect children from severe flu and reduce the spread of influenza in the community, and we need to increase access to these vaccines."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted August 2023
Read this next
COVID-19 Vaccination Not Tied to Adverse Pregnancy Outcomes
TUESDAY, June 25, 2024 -- mRNA COVID-19 vaccination during pregnancy is not associated with an increased risk of adverse pregnancy outcomes, according to a study published in the...
FDA Approves Capvaxive Pneumococcal 21-Valent Conjugate Vaccine
FRIDAY, June 21, 2024 -- The U.S. Food and Drug Administration has approved the Capvaxive pneumococcal 21-valent conjugate vaccine for the prevention of invasive pneumococcal...
No Evidence That Live Vaccines Are Unsafe for Patients on Dupilumab
FRIDAY, June 14, 2024 -- There is no evidence to suggest that administration of live vaccines to patients receiving dupilumab is unsafe, and vaccine efficacy is not affected by...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.